- Home
- NTRP vs BIAF Comparison
NTRP vs BIAF Comparison
Compare NTRP & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRP
- BIAF
- Stock Information
- Founded
- NTRP 1985
- BIAF 2014
- Country
- NTRP United States
- BIAF United States
- Employees
- NTRP N/A
- BIAF N/A
- Industry
- NTRP
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- NTRP
- BIAF Health Care
- Exchange
- NTRP NYSE
- BIAF Nasdaq
- Market Cap
- NTRP 12.7M
- BIAF 12.2M
- IPO Year
- NTRP N/A
- BIAF 2022
- Fundamental
- Price
- NTRP $3.44
- BIAF $0.30
- Analyst Decision
- NTRP Hold
- BIAF Hold
- Analyst Count
- NTRP 1
- BIAF 1
- Target Price
- NTRP $5.00
- BIAF N/A
- AVG Volume (30 Days)
- NTRP 56.6K
- BIAF 11.2M
- Earning Date
- NTRP 05-29-2025
- BIAF 08-13-2025
- Dividend Yield
- NTRP N/A
- BIAF N/A
- EPS Growth
- NTRP N/A
- BIAF N/A
- EPS
- NTRP N/A
- BIAF N/A
- Revenue
- NTRP $501,422.00
- BIAF $8,809,228.00
- Revenue This Year
- NTRP $2,544.87
- BIAF N/A
- Revenue Next Year
- NTRP N/A
- BIAF $20.00
- P/E Ratio
- NTRP N/A
- BIAF N/A
- Revenue Growth
- NTRP 9.30
- BIAF 78.40
- 52 Week Low
- NTRP $1.39
- BIAF $0.16
- 52 Week High
- NTRP $8.50
- BIAF $2.99
- Technical
- Relative Strength Index (RSI)
- NTRP 59.00
- BIAF 50.96
- Support Level
- NTRP $3.00
- BIAF $0.22
- Resistance Level
- NTRP $4.20
- BIAF $0.46
- Average True Range (ATR)
- NTRP 0.49
- BIAF 0.04
- MACD
- NTRP 0.02
- BIAF 0.01
- Stochastic Oscillator
- NTRP 47.59
- BIAF 30.51
About NTRP NEXTTRIP INC
NextTrip Inc is a technology-driven platform delivering travel booking and travel media solutions. It provides individual and group travelers with vacations to popular and sought-after destinations in Mexico, the Caribbean, and across the world. NextTrip Media platform - Travel Magazine offers a social media platform for viewers to explore, educate, and share with friends their bucket list travel. The company is also launching an end-to-end content ecosystem that uses AI-assisted travel planning capturing advertising, building brand awareness, rewarding loyalty, and driving bookings.
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.